<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04841603</url>
  </required_header>
  <id_info>
    <org_study_id>116/2020-01</org_study_id>
    <nct_id>NCT04841603</nct_id>
  </id_info>
  <brief_title>Brief Digital CBT for Mood and Anxiety Symptoms in Acute Psychiatric Inpatients</brief_title>
  <official_title>Brief Digital CBT for Mood and Anxiety Symptoms in Acute Psychiatric Inpatients: a Randomized Feasibility Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre for Addiction and Mental Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre for Addiction and Mental Health</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomized control trial examining the feasibility, acceptability, and preliminary efficacy&#xD;
      of providing access to the MindShift CBT mobile app via tablet for acute psychiatric&#xD;
      inpatients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Psychiatric inpatients expect more psychosocial intervention during their inpatient stay than&#xD;
      they receive. During the COVID-19 pandemic, existing interventions have been further reduced.&#xD;
      Mood and anxiety symptoms are common for all inpatients across diagnostic categories. Studies&#xD;
      have shown that cognitive behavioural therapy (CBT) can be effective for treating these&#xD;
      symptoms among inpatients. The purpose of this study is to determine whether the Mindshift&#xD;
      CBT app (an app based on principles of cognitive behavioural therapy) is an acceptable,&#xD;
      feasible, and useable intervention for inpatients.&#xD;
&#xD;
      The Mindshift CBT app is a tool designed and maintained by Anxiety Canada. It includes tools&#xD;
      for daily mood check-ins, healthy thinking, calming intense emotions, and taking actions to&#xD;
      change behaviours associated with anxiety and low mood. It also includes information about&#xD;
      the common types of anxiety.&#xD;
&#xD;
      The proposed trial includes 12 patients per arm. All participants in control and intervention&#xD;
      groups will have access to assigned tablet devices throughout the study period, though only&#xD;
      those in the intervention group will have the MindShift CBT app on their device. All&#xD;
      participants will undergo assessments at baseline and at the end of the intervention period&#xD;
      (1 week).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 12, 2021</start_date>
  <completion_date type="Actual">May 11, 2021</completion_date>
  <primary_completion_date type="Actual">May 11, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized control trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Retention rates</measure>
    <time_frame>1 week</time_frame>
    <description>Feasibility - whether the intervention is possible in the acute inpatient setting</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Recruitment rates</measure>
    <time_frame>1 week</time_frame>
    <description>Feasibility - whether the intervention is possible in the acute inpatient setting</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Client Satisfaction Questionnaire 8 (CSQ-8)</measure>
    <time_frame>1 week</time_frame>
    <description>Acceptability - whether the intervention is appropriate for the acute inpatient setting. The CSQ-8 scores range from 8 to 32, with higher values indicating higher satisfaction with the intervention.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>User Experience Questionnaire (UXQ)</measure>
    <time_frame>1 week</time_frame>
    <description>Usability - whether the intervention is serviceable for its intended purpose. The UXQ has 11 items exploring characteristics informing usability of mobile apps, each scored from 0-10, for a total score ranging from 10-110 (with larger scores indicating increased usability).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Qualitative Data Analysis</measure>
    <time_frame>1 week</time_frame>
    <description>From focus groups, to inform feasibility, usability, and acceptability</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient Health Questionnaire 9 (PHQ-9)</measure>
    <time_frame>1 week</time_frame>
    <description>Preliminary efficacy - whether symptoms of depression are improved by the intervention. PHQ-9 is scored from 0 to 27 with higher scores indicating increasing severity of symptoms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>General Anxiety Disorder 7 Scale (GAD-7)</measure>
    <time_frame>1 week</time_frame>
    <description>Preliminary efficacy - whether symptoms of anxiety are improved by the intervention. GAD-7 total score for the seven items ranges from 0 to 21. Scores of 5, 10, and 15 represent cut points for mild, moderate, and severe anxiety.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Kessler Psychological Distress Scale (K10)</measure>
    <time_frame>1 week</time_frame>
    <description>Preliminary efficacy - whether symptoms of distress are improved by the intervention. Scores range from 10 to 50, with increasing scores indicating increasing distress and severity of symptoms.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Anxiety</condition>
  <condition>Depressive Symptoms</condition>
  <condition>Distress, Emotional</condition>
  <condition>Anxiety and Fear</condition>
  <condition>Anxiety State</condition>
  <condition>Mental Disorders, Severe</condition>
  <condition>Psychiatric Hospitalization</condition>
  <arm_group>
    <arm_group_label>Treatment as usual</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Treatment as usual</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mindshift CBT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment as usual + Access to Mindshift CBT app</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Mindshift CBT</intervention_name>
    <description>A tablet with the Mindshift CBT app installed. Mindshift CBT is a free, evidence based app developed by Anxiety Canada, designed to help users reduce symptoms of anxiety and distress.</description>
    <arm_group_label>Mindshift CBT</arm_group_label>
    <other_name>CBT mobile app</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Treatment as Usual</intervention_name>
    <description>Treatment as usual. A tablet identical to the intervention group, but without the Mindshift CBT app is available for patients to use during their inpatient stay.</description>
    <arm_group_label>Treatment as usual</arm_group_label>
    <other_name>Tablet</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Admitted to the acute inpatient unit&#xD;
&#xD;
          -  Fluent in English&#xD;
&#xD;
          -  Dynamic Appraisal for Situational Aggression (DASA) score &lt;=3&#xD;
&#xD;
          -  Capable to consent to participation as assessed by the treating physician&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of moderate-severe learning disability&#xD;
&#xD;
          -  Diagnosis of moderate-severe neurocognitive disorder&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ishrat Husain, MBBS, MD (Res.), MRCPsych</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre for Addiction and Mental Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre for Addiction and Mental Health</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M6J1H4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>Radcliffe J, Smith R. Acute in-patient psychiatry: how patients spend their time on acute psychiatric wards. Psychiatric Bulletin. 2007 May;31(5):167-70.</citation>
  </reference>
  <reference>
    <citation>KÃ¶sters M, Burlingame GM, Nachtigall C, Strauss B. A meta-analytic review of the effectiveness of inpatient group psychotherapy. Group Dynamics: Theory, Research, and Practice. 2006 Jun;10(2):146.</citation>
  </reference>
  <reference>
    <citation>Xia J, Merinder LB, Belgamwar MR. Psychoeducation for schizophrenia. Cochrane Database Syst Rev. 2011 Jun 15;(6):CD002831. doi: 10.1002/14651858.CD002831.pub2. Review.</citation>
    <PMID>21678337</PMID>
  </reference>
  <reference>
    <citation>Cuijpers P, Clignet F, van Meijel B, van Straten A, Li J, Andersson G. Psychological treatment of depression in inpatients: a systematic review and meta-analysis. Clin Psychol Rev. 2011 Apr;31(3):353-60. doi: 10.1016/j.cpr.2011.01.002. Epub 2011 Jan 16. Review.</citation>
    <PMID>21382540</PMID>
  </reference>
  <reference>
    <citation>Hopkins JE, Loeb SJ, Fick DM. Beyond satisfaction, what service users expect of inpatient mental health care: a literature review. J Psychiatr Ment Health Nurs. 2009 Dec;16(10):927-37. doi: 10.1111/j.1365-2850.2009.01501.x. Review.</citation>
    <PMID>19930367</PMID>
  </reference>
  <reference>
    <citation>Paul AM, Fleming CJ. Anxiety management on campus: an evaluation of a mobile health intervention. J Technol Behav Sci 2018 Sep 19;4(1):58-61.</citation>
  </reference>
  <reference>
    <citation>Marshall JM, Dunstan DA, Bartik W. Effectiveness of Using Mental Health Mobile Apps as Digital Antidepressants for Reducing Anxiety and Depression: Protocol for a Multiple Baseline Across-Individuals Design. JMIR Res Protoc. 2020 Jul 5;9(7):e17159. doi: 10.2196/17159.</citation>
    <PMID>32623368</PMID>
  </reference>
  <reference>
    <citation>Attkisson CC, Zwick R. The client satisfaction questionnaire. Psychometric properties and correlations with service utilization and psychotherapy outcome. Eval Program Plann. 1982;5(3):233-7.</citation>
    <PMID>10259963</PMID>
  </reference>
  <reference>
    <citation>Husain MO et al. Evaluating the feasibility and acceptability of mobile health apps that deliver psychosocial interventions: using functional criteria to capture the user's experience (under review). Digital Health 2020.</citation>
  </reference>
  <reference>
    <citation>Julious SA. Sample size of 12 per group rule of thumb for a pilot study. Pharmaceutical Statistics: The Journal of Applied Statistics in the Pharmaceutical Industry. 2005 Oct;4(4):287-91.</citation>
  </reference>
  <reference>
    <citation>Braun V, Clarke V. Using thematic analysis in psychology. Qualitative research in psychology. 2006 Jan 1;3(2):77-101.</citation>
  </reference>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>March 30, 2021</study_first_submitted>
  <study_first_submitted_qc>April 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 12, 2021</study_first_posted>
  <last_update_submitted>July 26, 2021</last_update_submitted>
  <last_update_submitted_qc>July 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre for Addiction and Mental Health</investigator_affiliation>
    <investigator_full_name>Gaurav Sharma</investigator_full_name>
    <investigator_title>Resident Physician</investigator_title>
  </responsible_party>
  <keyword>inpatient psychiatry</keyword>
  <keyword>psychiatric admission</keyword>
  <keyword>mobile app</keyword>
  <keyword>inpatient CBT</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anxiety Disorders</mesh_term>
    <mesh_term>Mental Disorders</mesh_term>
    <mesh_term>Depression</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

